International Pharmaceutical Federation

Codify Self-Care for Advancement of Universal Health Coverage, Says United for Self-Care Coalition at WHA76

Retrieved on: 
Thursday, May 25, 2023
FIP, Primary health care, PHC, International, Coalition, World Health Assembly, Health equity, Quality of life, International Pharmaceutical Federation, Organization, European Platform for Patients' Organisations, Science and Industry, CH, Patient, UHC, Imperial College London, GENEVE, Health, WHO, Notifiable disease, Biofeedback Certification International Alliance, World Health Organization, Nursing, Pharmaceutical industry, United

Embedding self-care practices into the healthcare continuum has the potential to improve health and quality of life whilst promoting health system sustainability.

Key Points: 
  • Embedding self-care practices into the healthcare continuum has the potential to improve health and quality of life whilst promoting health system sustainability.
  • Speakers highlighted the potential benefits of self-care, including improved health outcomes, increased access to healthcare services, stronger health systems and reduced healthcare costs.
  • "The United for Self-Care Coalition is proud to have hosted this important side event at the World Health Assembly," said Judy Stenmark, Director General of the Global Self-Care Federation.
  • For more information about the United for Self-Care Coalition and details on how to join, please visit https://www.unitedforselfcare.org

Sixfold Bioscience Announces Formation of Scientific Advisory Board

Retrieved on: 
Wednesday, August 9, 2023
Health, Technology, Research, Artificial Intelligence, Science, Pharmaceutical, Biotechnology, GSK, United States Air Force Scientific Advisory Board, Sixfold Expanse of Samantabhadra, Cell, RNA, Thought, Patient, AI, International Pharmaceutical Federation, FDA, Therapy, Prosensa, Disease, Vaccine

Sixfold Bioscience, a leading AI-enabled RNA delivery company that leverages the body’s evolved delivery pathways, is pleased to announce the formation of its Scientific Advisory Board.

Key Points: 
  • Sixfold Bioscience, a leading AI-enabled RNA delivery company that leverages the body’s evolved delivery pathways, is pleased to announce the formation of its Scientific Advisory Board.
  • The board comprises world-renowned industry experts who will provide strategic guidance and scientific advice as the company advances its development pipeline.
  • The Scientific Advisory Board members are:
    "We are thrilled to welcome this esteemed group of experts to our Scientific Advisory Board," said Dr. Anna Perdrix Rosell, co-founder and co-CEO of Sixfold Bioscience.
  • The formation of the Scientific Advisory Board is a significant milestone for Sixfold Bioscience as it continues to develop cutting-edge RNA delivery technology.

P&G Health Bolsters Commitment to "Total Body Health" at the 1st Middle East Whole Body Health Symposium' 2022

Retrieved on: 
Monday, September 26, 2022
Shoulder, Symposium, B vitamins, Febreze, Pregnancy, General Health System (Cyprus), Digestive, Omeprazole, Knowledge, Organization, Pharmacy, International Pharmaceutical Federation, Head & Shoulders, Mineral, Total body irradiation, P&G, Endocrinology, Patient, Pantene, Oral, CAPP, Pharmacist, Pain, Quality of life, Gillette, Vicks, File association, Psyllium, Oral hygiene, Heart, Associate, Miracle Mineral Supplement, FIP, Awareness, Health, Vitamin, Maternal health, Education, California Dental Association, Medicine, Healthcare, Pharmaceutical industry, Tide, Crest, Whispering, Pampers, Doctor of Philosophy

Ahead of World Pharmacists Day 2022, the Symposium highlighted the critical role of Pharmacists in timely diagnoses, education, and management

Key Points: 
  • Ahead of World Pharmacists Day 2022, the Symposium highlighted the critical role of Pharmacists in timely diagnoses, education, and management
    DUBAI, UAE, Sept. 26, 2022 /PRNewswire/ -- P&G Health renewed its commitment to holistically-driven "Total Body Health" at its first P&G Health Middle East Whole Body Health Symposium' onSeptember 23 & 24, 2022.
  • Pharmacists were spotlighted for their role in improving health outcomes by providing counsel on daily self-care habits, timely diagnoses, education, and management.
  • With growth opportunities in consumer health and wellness segments, P&G Health is demonstrating through focused and continued innovation how unlocking the power of well-informed health professionals can facilitate 'Total Body Health' in the region and beyond."
  • About P&G Health Middle East:
    P&G strives to improve the lives of 90 million consumers in the Arabian Peninsula & Levant region.

P&G Health Bolsters Commitment to "Total Body Health" at the 1st Middle East Whole Body Health Symposium' 2022

Retrieved on: 
Monday, September 26, 2022
Shoulder, Symposium, B vitamins, Febreze, Pregnancy, General Health System (Cyprus), Digestive, Omeprazole, Knowledge, Organization, Pharmacy, International Pharmaceutical Federation, Head & Shoulders, Mineral, Total body irradiation, P&G, Endocrinology, Patient, Pantene, Oral, CAPP, Pharmacist, Pain, Quality of life, Gillette, Vicks, File association, Psyllium, Oral hygiene, Heart, Associate, Miracle Mineral Supplement, FIP, Awareness, Health, Vitamin, Multimedia, Maternal health, Education, Uganda Dental Association, Medicine, Healthcare, Pharmaceutical industry, Tide, Crest, Whispering, Pampers, Doctor of Philosophy

Ahead of World Pharmacists Day 2022, the Symposium highlighted the critical role of Pharmacists in timely diagnoses, education, and management

Key Points: 
  • Ahead of World Pharmacists Day 2022, the Symposium highlighted the critical role of Pharmacists in timely diagnoses, education, and management
    DUBAI, UAE, Sept. 26, 2022 /PRNewswire/ -- P&G Health renewed its commitment to holistically-driven "Total Body Health" at its first P&G Health Middle East Whole Body Health Symposium' onSeptember 23 & 24, 2022.
  • Pharmacists were spotlighted for their role in improving health outcomes by providing counsel on daily self-care habits, timely diagnoses, education, and management.
  • With growth opportunities in consumer health and wellness segments, P&G Health is demonstrating through focused and continued innovation how unlocking the power of well-informed health professionals can facilitate 'Total Body Health' in the region and beyond."
  • About P&G Health Middle East:
    P&G strives to improve the lives of 90 million consumers in the Arabian Peninsula & Levant region.

Dr. Régis Vaillancourt, designated as vice-president of pharmacy affaire at BCE Pharma

Retrieved on: 
Thursday, May 5, 2022
Pharmacist, Ontario Colleges Athletic Association, Society, International Pharmaceutical Federation, Canadian Society of Hospital Pharmacists, University, GLOBE, Awards and decorations of the Civil Air Patrol, National Association, FIP, Health literacy, CHEO, Organization, Association, Accreditation, Engineers Without Borders (Canada), Lieutenant colonel, Canadian Pharmacists Association, Pharmacy, BCE, Canada, International, Suite (music), Pharmaceutical industry

ST-GEORGES, Quebec, May 05, 2022 (GLOBE NEWSWIRE) -- Dr. Rgis Vaillancourt is joining BCE pharma as the vice president of pharmacy affaire at BCE Pharma, the Canadian leader with its quality management program for compounding preparations in pharmacy.

Key Points: 
  • ST-GEORGES, Quebec, May 05, 2022 (GLOBE NEWSWIRE) -- Dr. Rgis Vaillancourt is joining BCE pharma as the vice president of pharmacy affaire at BCE Pharma, the Canadian leader with its quality management program for compounding preparations in pharmacy.
  • The companys mission is to provide service and to give support and advice to organizations to help them meet the required standards in effect.
  • Throughout his career, Dr. Vaillancourt has worked with different pharmacy organizations.
  • Dr. Vaillancourt has published more than 100 peer reviewed articles on pharmacy practice with a focus on medication safety and health literacy.

GSK Consumer Healthcare solidifies commitment to pharmacists with 3-year Pharmacist Support Programme, helping global pharmacy teams play a critical role in improving public health in the age of self-care

Retrieved on: 
Tuesday, October 26, 2021
Pharmacy, Science, Workload, Research, Remuneration, International, FIP, McNeil Consumer Healthcare, International Pharmaceutical Federation, Patient, World Health Organization, Pharmacist, Policy, Trust, World, Communication, Intention, Mental health, Health, OTC, COVID-19, Health literacy, Dentistry, GlaxoSmithKline, Education, Health insurance, Pharmaceutical industry, Healthcare

Yet in general, pharmacists remain under-utilised, despite being the most widely distributed health resource in Europe," said Tess Player, Global Head of Expert at GSK Consumer Healthcare.

Key Points: 
  • Yet in general, pharmacists remain under-utilised, despite being the most widely distributed health resource in Europe," said Tess Player, Global Head of Expert at GSK Consumer Healthcare.
  • The report identifies six barriers faced by the global pharmacy community that can prevent them from fulfilling their critical role.
  • Year 1 (2021-22):Focus will be on providing mental health and wellbeing support for pharmacists and pharmacy teams.
  • Year 2 will also include helping pharmacists identify and support health literacy challenges via a health literacy assessment tool.

GSK Consumer Healthcare solidifies commitment to pharmacists with 3-year Pharmacist Support Programme, helping global pharmacy teams play a critical role in improving public health in the age of self-care

Retrieved on: 
Tuesday, October 26, 2021
Pharmacy, Science, Workload, Research, Remuneration, International, FIP, McNeil Consumer Healthcare, International Pharmaceutical Federation, Patient, World Health Organization, Pharmacist, Policy, Trust, World, Communication, Intention, Mental health, Health, OTC, COVID-19, Health literacy, Dentistry, GlaxoSmithKline, Education, Health insurance, Pharmaceutical industry, Healthcare

Yet in general, pharmacists remain under-utilised, despite being the most widely distributed health resource in Europe," said Tess Player, Global Head of Expert at GSK Consumer Healthcare.

Key Points: 
  • Yet in general, pharmacists remain under-utilised, despite being the most widely distributed health resource in Europe," said Tess Player, Global Head of Expert at GSK Consumer Healthcare.
  • The report identifies six barriers faced by the global pharmacy community that can prevent them from fulfilling their critical role.
  • Year 1 (2021-22):Focus will be on providing mental health and wellbeing support for pharmacists and pharmacy teams.
  • Year 2 will also include helping pharmacists identify and support health literacy challenges via a health literacy assessment tool.

2021 Centre for Medicines Research (CMR) Pharmaceutical R&D Factbook from Clarivate Finds Drug Approvals at a 10-year High Despite the Challenges of COVID-19

Retrieved on: 
Wednesday, September 15, 2021
Science, PMDA, The Science Group, Drug discovery, Tetanic contraction, R, The World Factbook, FDA, Drug development, Efficiency, Intellectual property, Invention, PDMA, Patient, Research, Pharma, EMA, Medication, D, Clinical Medicine & Research, CMR, Annual report, NYSE, Center, Industry, Solution, KPI-driven code analysis, COVID-19, International Pharmaceutical Federation, TNF, NME, Pharmaceutical industry, Fine chemical, Vaccine

This year's report finds that the pharmaceutical industry has responded well to the challenges of COVID-19.

Key Points: 
  • This year's report finds that the pharmaceutical industry has responded well to the challenges of COVID-19.
  • The Centre for Medicines Research, a wholly owned subsidiary of Clarivate, has released the 2021 Centre for Medicines Research (CMR) Pharmaceutical R&D Factbook to help pharma and biotech companies benchmark their drug development efforts against industry leaders.
  • From the CMR Factbook we can infer that there has been no major impact from COVID-19 on the R&D pipeline thus far.
  • To learn more about the 2021 Centre for Medicines Research (CMR) International Pharmaceutical R&D Factbook, visit here .

2021 Centre for Medicines Research (CMR) Pharmaceutical R&D Factbook from Clarivate Finds Drug Approvals at a 10-year High Despite the Challenges of COVID-19

Retrieved on: 
Wednesday, September 15, 2021
Science, PMDA, The Science Group, Drug discovery, Tetanic contraction, R, The World Factbook, FDA, Drug development, Efficiency, Intellectual property, Invention, PDMA, Patient, Research, Pharma, EMA, Medication, D, Clinical Medicine & Research, CMR, Annual report, NYSE, Center, Industry, Solution, KPI-driven code analysis, COVID-19, International Pharmaceutical Federation, TNF, NME, Fine chemical, Pharmaceutical industry, Vaccine

LONDON, Sept. 15, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of the 2021 Centre for Medicines Research (CMR) International Pharmaceutical R&D Factbook. The 2021 CMR R&D Factbook centers on how the pandemic may have impacted drug launches, development times and approvals. This year's report finds that the pharmaceutical industry has responded well to the challenges of COVID-19. In fact, 2020 saw a 10-year high of new molecular entities (NMEs) launched into the world market.

Key Points: 
  • This year's report finds that the pharmaceutical industry has responded well to the challenges of COVID-19.
  • The Centre for Medicines Research, a wholly owned subsidiary of Clarivate, has released the 2021 Centre for Medicines Research (CMR) Pharmaceutical R&D Factbook to help pharma and biotech companies benchmark their drug development efforts against industry leaders.
  • From the CMR Factbook we can infer that there has been no major impact from COVID-19 on the R&D pipeline thus far.
  • To learn more about the 2021 Centre for Medicines Research (CMR) International Pharmaceutical R&D Factbook, visit here .

Greenfield Global Ireland Ready to Supply Life Science Customers Globally

Retrieved on: 
Tuesday, September 14, 2021
Validity (statistics), Citric acid, CEO, Quality control, Health, OQ, WFI, GMP, Sodium hydroxide, International Pharmaceutical Excipients Council, Running, IPEC, USP, PQ, Food, COVID-19, Solvent, Carbon footprint, Water, Ethanol, Good manufacturing practice, GLOBE, International Pharmaceutical Federation, Commercial, Animal, Fine chemical

The facility, which has been commissioned and validated, is set to supply life science customers with its Pharmco products in Ireland, Europe and elsewhere around the world.

Key Points: 
  • The facility, which has been commissioned and validated, is set to supply life science customers with its Pharmco products in Ireland, Europe and elsewhere around the world.
  • Located in the heart of Ireland, Greenfield is strategically positioned to serve life science customers throughout the country as well as the rest of Europe.
  • Greenfield Global has supplied essential alcohols, solvents and bio-processing materials from our North American operations to customers in the life science industry for more than three decades, helping them improve the health of people around the world, said Howard Field, Greenfield Global President and CEO.
  • We are beyond excited to supply new and existing life science customers with Pharmco-branded products, especially in times of globally damaged supply chains as a result of the COVID-19 pandemic, Finegan added.